Hedge funds piled into short positions on US stocks as concerns about disruption to business models from artificial intelligence reverberated through markets. Notional short selling across single stocks last week was the biggest on record in Goldman Sachs Group Inc. data going back to 2016, the bank’s prime brokerage team said in a client note. Short sales outpaced long buys by a magnitude of two-...
Hedge funds piled into short positions on US stocks as concerns about disruption to business models from artificial intelligence reverberated through markets. Notional short selling across single stocks last week was the biggest on record in Goldman Sachs Group Inc. data going back to 2016, the bank’s prime brokerage team said in a client note. Short sales outpaced long buys by a magnitude of two-to-one, the team including Vincent Lin said, citing flows from the Jan. 30 to Feb. 5 period. Anxiety over how AI will transform the economy boiled over into a turbulent week on Wall Street, with a selloff sparked by Anthropic PBC’s new tools designed to automate work tasks in a number of industries. A group of 164 stocks in the software, financial services and asset management sectors lost $611 billion in market value last week. Overall, hedge funds net sold US equities for a fourth week and at the heaviest rate since the so-called Liberation Day in early April. Information technology was the most heavily sold sector, posting the second-largest dollar outflows in the past five years, the Goldman team said. Software dominated the retreat, accounting for about 75% of net selling within the sector. The funds’ aggregate net exposure to software equities fell to 2.6%, while the long-short ratio slid to 1.3 — both marking record lows. Semiconductors and semiconductor equipment, along with IT services, were among the few technology-related areas to see net buying during the week. A gauge of semiconductor stocks rose last week, deepening the divergence between chip stocks and software shares that’s been widening in recent months as investors punish the industries they worry could be disrupted by AI. Outside tech, hedge funds continued to rotate into defensive areas. Health care was the most net-bought sector last week and has now become the top destination for hedge fund inflows year-to-date, overtaking industrials, the Goldman team said. Stocks rebounded on Friday as dip-buyers em...
With China explicitly banning onshore tokenisation of real-world assets (RWAs) while tightening scrutiny of related offshore activities, analysts say the clampdown is aimed at curbing financial fraud and disorderly capital outflows, while still preserving space for regulated innovation in markets such as Hong Kong. Tokenisation refers to the process of converting the rights to an RWA – including r...
With China explicitly banning onshore tokenisation of real-world assets (RWAs) while tightening scrutiny of related offshore activities, analysts say the clampdown is aimed at curbing financial fraud and disorderly capital outflows, while still preserving space for regulated innovation in markets such as Hong Kong. Tokenisation refers to the process of converting the rights to an RWA – including real estate, art, bonds and commodities like gold – into a digital token. Such tokens represent ownership, enabling easier trading, increased liquidity and fractional ownership for previously illiquid assets. Currently, many so-called RWA investments within mainland China are, in essence, financial scams, said Liu Xiaochun, vice-president of the China Academy of Financial Research at Shanghai Jiao Tong University. Advertisement “First, there are too many scammers nowadays,” he explained. “Second, there are also numerous cases of capital outflow being conducted using either RWAs or crypto assets. That’s why a ban is necessary.” The announcement , jointly released by the People’s Bank of China and seven other government agencies, made it clear that domestic entities, as well as offshore entities under their control, could not issue virtual currencies overseas without approval. Advertisement Crucially, no entities – Chinese or foreign – are allowed to issue yuan-pegged offshore stablecoins without approval. Stablecoins are cryptocurrencies designed to minimise volatility by pegging to a stable asset, typically a fiat currency such as the US dollar.
(RTTNews) - Cleveland-Cliffs Inc. (CLF) will host a conference call at 8:30 AM ET on February 9, 2026, to discuss Q4 25 earnings results. To access the live webcast, log on to https://www.clevelandcliffs.com/investors/news-events/ir-calendar The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
(RTTNews) - Cleveland-Cliffs Inc. (CLF) will host a conference call at 8:30 AM ET on February 9, 2026, to discuss Q4 25 earnings results. To access the live webcast, log on to https://www.clevelandcliffs.com/investors/news-events/ir-calendar The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Energy security is once again at the very heart of the global geopolitical arena. In an era defined by conflict, sanctions and increasingly precarious maritime routes, Beijing has internalised a fundamental truth: in an unstable world, resilience trumps ideology. Recent disruptions to global shipping corridors and tightening sanction regimes have reinforced this shift, pushing major economies to r...
Energy security is once again at the very heart of the global geopolitical arena. In an era defined by conflict, sanctions and increasingly precarious maritime routes, Beijing has internalised a fundamental truth: in an unstable world, resilience trumps ideology. Recent disruptions to global shipping corridors and tightening sanction regimes have reinforced this shift, pushing major economies to reassess their exposure to external supply shocks. While much of the West remains locked in a debate over the pace of the energy transition, China is quietly forging a multilayered “energy shield”, designed not to choose between old and new systems, but to immunise its economy against external shocks and price turbulence. Advertisement The 2025 production figures tell a story of strategic intent. China’s oil and gas output reached record highs last year, driven by rapid growth in offshore extraction and unconventional shale resources. This reflects sustained policy support aimed at strengthening domestic supply capacity. Every barrel pumped at home is one that does not have to navigate a contested strait or fall prey to the volatility of global markets. While domestic supply cannot yet achieve total self-sufficiency, it provides a critical strategic buffer, ensuring geopolitical friction abroad does not easily translate into industrial disruption at home. Advertisement
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Spotify . Getty Images Survey Monday Precious metals and crypto to the labor market and $1T club! Dive into the latest hot themes in the SA Sentiment Survey for February, which explores the investing decisions of the Seeking Alpha community. Click here to take the poll and don't fo...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Spotify . Getty Images Survey Monday Precious metals and crypto to the labor market and $1T club! Dive into the latest hot themes in the SA Sentiment Survey for February, which explores the investing decisions of the Seeking Alpha community. Click here to take the poll and don't forget to share your thoughts in the WSB comments section . Good morning! Here's the latest in trending: Seahawks prevail: The Super Bowl indicator returns as Wall Street's superstition and check out a recap of some of the most notable corporate ads . U.S. Treasuries: Chinese regulators have reportedly asked major financial institutions to limit their exposure , citing concentration risk and market volatility. The final frontier: SpaceX is now prioritizing building a city on the moon over Mars , while iPhones might be journeying where no smartphones have gone before . Copycat spat A high-profile fight in the world of compounded drugs looks like it has been resolved, with telehealth firm Hims & Hers ( HIMS ) backing off a plan to offer a knockoff Wegovy pill for as little as $49 (which would be $100 less than what Novo Nordisk ( NVO ) charges for its branded pill). Shares of NVO are on the move again premarket, soaring another 7% on the news, while HIMS shares are down 16% in early trading. However, questions continue to surface about cheaper medication alternatives, regulations, and the marketing of these products to the general population. What are compounded drugs? These medicines are generally more affordable and accessible than the big-name brands, but consumers still need a prescription from a doctor to purchase these "compounds"—in this case, semaglutide. While both official drugmakers and compounding pharmacies have to source active pharmaceutical ingredients (APIs) from FDA-registered manufacturers, the difference is in the final mixed product. Drugs from commercial p...
Jefferies describes it as “SaaSapocalypse” as fears around software companies losing their relevance gain more traction by the day. The idea is that leading AI companies such as ChatGPT-parent OpenAI and Anthropic's Claude will replace the work done by software companies eventually. The jury may still be out on the perceived demise of the software industry, and the reality is actually much more nu...
Jefferies describes it as “SaaSapocalypse” as fears around software companies losing their relevance gain more traction by the day. The idea is that leading AI companies such as ChatGPT-parent OpenAI and Anthropic's Claude will replace the work done by software companies eventually. The jury may still be out on the perceived demise of the software industry, and the reality is actually much more nuanced than this. However, sentiments have turned against the sector, and investors are heading just one way: exit. Panic-induced selling in the software stocks has resulted in the shares of the world's largest ETF by AUM—the North American Tech-Software iShares ETF (IGV)—covering the sector declining by 24.6% on a YTD basis. Yet, the words of a familiar friend may act as a savior for the industry. Ives to the Rescue Popular global head of technology research at Wedbush Securities, Dan Ives, along with his band of analysts, believes the current selloff is overdone and the fears around the sector, overblown. Making a case for the software sector, the firm's analysts remarked: "We believe the market is baking in a doomsday scenario for software companies in the near-term, which we believe is extremely overblown, as many customers won’t be willing to put their data at risk to capitalize on AI implementation strategies until there is less risk with these migration projects. Is AI a headwind in the near-term for software? YES!...however, the magnitude of this software sell-off is a major head scratcher and is factoring in an Armageddon scenario for the sector that is far from reality in our view." Ives's bullishness about the software sector has been longstanding. Yet, it is not for all the names. Which ones, then? Here are the five names that Ives and his team believe have it in them to navigate the present challenges and emerge as winners. Software Stock #1: Palantir (PLTR) Starting with an Ives favorite in Palantir (PLTR). Dubbed as the “Messi of AI” by Ives, Palantir is a sof...
JHVEPhoto/iStock Editorial via Getty Images The investment thesis for 8x8 ( EGHT ) in recent quarters has centered on the ongoing deleveraging alongside revenue headwinds related to customer churn from its now-shutdown Fuze platform . Despite structural demand challenges following the post-COVID overbuying and a competitive environment, EGHT’s management has made steady progress in improving the c...
JHVEPhoto/iStock Editorial via Getty Images The investment thesis for 8x8 ( EGHT ) in recent quarters has centered on the ongoing deleveraging alongside revenue headwinds related to customer churn from its now-shutdown Fuze platform . Despite structural demand challenges following the post-COVID overbuying and a competitive environment, EGHT’s management has made steady progress in improving the company’s financial performance. Q3 results demonstrated that execution remains solid, even though growth and margin metrics remain unappealing. Following the post-earnings rally of over 50%, shares are not cheap relative to peers, especially given its high debt load. While I am more cautious now and leaning slightly bearish following the share price rise, I do acknowledge that there is room for this management team to surprise to the upside from cross-selling its AI offerings and sustaining the growth in Asia. As a result, I am maintaining my hold rating on the stock. 8x8's Q3 Results Exceed Expectations, and Guidance is Raised The company's Q3 FY26 results exceeded the guidance ranges for top and bottom-line metrics. Service revenue of $179.7 million grew 3.6% year-over-year, with underlying growth of 5% when adjusting for the Fuze customer churn. Non-GAAP operating profit correspondingly grew 15% to $21.7 million. While the headline numbers look promising, I see some less appealing aspects when I delve in further. First, gross margins remain under pressure, as shown below, due to the mix shift toward usage-based offerings. EGHT's customers are increasingly moving from a seat-based model to a usage-based model, including greater use of its AI offerings . Q3 Shareholder Letter Overall gross profit in Q3 was $118.2 million, down 2.4% versus the prior year quarter. On this topic, management struck a positive note stating : Gross margins on our usage-based business are probably structurally slightly lower than on our SaaS business because you don't have shelfware and you don't...
wildpixel/iStock via Getty Images Introduction So far, this year, we have spent even more time than usual on the market rotation, as I expect value stocks to generate substantial alpha this year (and beyond!). This article is not primarily about that. In this article, I'll discuss a major engine of this rotation, which is what I like to call QE-like data center spending. One of my favorite charts ...
wildpixel/iStock via Getty Images Introduction So far, this year, we have spent even more time than usual on the market rotation, as I expect value stocks to generate substantial alpha this year (and beyond!). This article is not primarily about that. In this article, I'll discuss a major engine of this rotation, which is what I like to call QE-like data center spending. One of my favorite charts is the updated one below, which shows analysts expect close to $560 billion in capital expenditures ("CapEx") from just five hyperscalers. That would be up from $71 billion in 2019 and account for roughly a third of their revenues. On a longer-term basis, we are looking at many trillions in spending. And that's not even a wild guess. JPMorgan My thesis is simple, which is that this money will mostly end up in the "real" economy, as data centers will be built, power plants have to be constructed, employees need to be paid, machinery needs to be purchased/rented, materials are needed, and so much more. Moreover, this capital is hitting bottlenecks. One thing I brought up this year is a statement from Elon Musk, as he made the case that many GPUs (advanced chips) for data centers will be bought but not used, as there isn't sufficient power to operate them. "I think the limiting factor for AI deployment is fundamentally electrical power," Musk said. "It's clear that we're very soon - maybe even later this year - we'll be producing more chips than we can turn on." - Elon Musk (via Yahoo Finance ) Now, after listening to all major earnings calls and spending even more time doing my homework, it seems my thesis is only getting stronger, as even these CapEx estimates seem to be conservative. Essentially, this strengthens a core pillar of my "broadening growth" thesis, which is critical for capital allocation. Hence, this article is all about that thesis, as I explain what is happening to these CapEx estimates, why it matters so much, and (even more important) specific stocks that I...
Company to host a webcast today at 8:30 am Eastern Time NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome...
Company to host a webcast today at 8:30 am Eastern Time NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today reported financial results for its first quarter of fiscal 2026. “As we have entered 2026, we continue to progress our innovative clinical pipeline with particular focus on our lead candidate, oral blarcamesine in early Alzheimer's disease. Based on our commitment to improving the lives of patients with neurological disorders, we remain excited about the therapeutic potential of oral blarcamesine. We look forward to working with the regulatory agencies in Europe and the U.S. to advance oral blarcamesine as a potential new treatment option for patients.” said Christopher U. Missling, PhD, President and CEO of Anavex. “An estimated 7.2 million people in the U.S. and 7 million in Europe are living with Alzheimer’s disease. Our mission is to develop targeted, orally delivered therapies aimed at a range of CNS related diseases, and specifically early-stage Alzheimer’s, where intervention may have the greatest impact.” Expected Development Milestones: Update on regulatory pathway for blarcamesine in early Alzheimer’s disease Progress on clinical development program in Parkinson’s disease through targeted approach, potentially addressing the highest disease burden in Parkinson’s disease Regulatory and clinical trial update for blarcamesine in Parkinson’s disease Regulatory and clinical trial update for blarcamesine in Rett syndrome Fragile X development update: Design of Phase 2/3 clinical trial Advancing ANAVEX ® 3-71 towards pivotal clinical studies for the treatment of schizophrenia related disorders 3-71 towards pivotal...
The ipushpull data sharing and workflow platform enables the delivery of real-time data on demand into client applications such as chat and Excel, all integrated into configurable workflows. ipushpull complements and enhances existing data distribution and dedicated screens with its omnichannel delivery model, providing a wide choice of delivery options through a single integration, including chat...
The ipushpull data sharing and workflow platform enables the delivery of real-time data on demand into client applications such as chat and Excel, all integrated into configurable workflows. ipushpull complements and enhances existing data distribution and dedicated screens with its omnichannel delivery model, providing a wide choice of delivery options through a single integration, including chatbots, Microsoft Excel and APIs, while replacing inefficient manual, email and file-based workflows. “As trading firms manage risk and exposure across multiple markets, access to exchange data needs to extend beyond the point of execution,” said Russell Robertson, Chief Business Development Officer at Abaxx Exchange. “Partnering with ipushpull enables us to deliver mission-critical pricing and trade data directly into the tools our clients rely on most, removing friction and supporting greater engagement with our markets.” “Microsoft Excel remains the beating heart of trading desks worldwide,” said Robert Kingham, Head of Strategic Partnerships at ipushpull. “With this partnership, we’re enabling Abaxx to meet clients where they already work, while ensuring scale, security, and efficiency through our enterprise-grade Data-as-a-Service platform.” As Microsoft Excel continues to serve as a core tool across global trading desks, the integration enables Abaxx Exchange market data to be accessed directly within the spreadsheets many firms already use to price risk, monitor positions, and manage exposure. Firms can subscribe to specific Abaxx datasets — including both historical and real-time feeds — with real-time values updating as the exchange publishes new data across active contracts. TORONTO, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (CBOE:ABXX)(OTCQX:ABXXF) (“ Abaxx ” or the “ Company ”), a financial software and market infrastructure company, majority shareholder of Abaxx Singapore Pte Ltd., the owner of Abaxx Commodity Exchange and Clearinghouse (individua...
Berkshire Hathaway is giving up on struggling Kraft Heinz, but Coca-Cola remains an industry leader. Warren Buffett had a simple investment approach: Buy well-run companies when they are attractively priced and hold for the long term. But even Buffett, the longtime former chief executive officer of Berkshire Hathaway (BRK.A +0.74%)(BRK.B +0.83%), made mistakes. Which is why Greg Abel, Buffett's su...
Berkshire Hathaway is giving up on struggling Kraft Heinz, but Coca-Cola remains an industry leader. Warren Buffett had a simple investment approach: Buy well-run companies when they are attractively priced and hold for the long term. But even Buffett, the longtime former chief executive officer of Berkshire Hathaway (BRK.A +0.74%)(BRK.B +0.83%), made mistakes. Which is why Greg Abel, Buffett's successor, is planning to dump Kraft Heinz (KHC +0.86%). But Coca-Cola (KO +0.80%) is still in the portfolio and isn't likely to be dropped anytime soon. Follow Abel's lead Buffett got involved in the Kraft Heinz company before the merger of those two iconic food brand names. In fact, he supported the merger that created the entity. Only the original plan to increase earnings by cutting costs didn't pan out as well as hoped. After struggling for years to turn the business around, Kraft Heinz has decided to abandon the merger and split itself in two again. Merging two struggling companies didn't make one good company. And breaking up one struggling business isn't likely to make two good companies. Greg Abel has signaled he's moving on from Kraft Heinz, and you may want to, as well. There's just no clear indication that the breakup will be a catalyst for better financial performance. Still, this is a good reminder that even great investors like Buffett aren't infallible. Coca-Cola is a reliable Dividend King One stock you may want to buy, however, is Coca-Cola. It is a longtime holding for Berkshire Hathaway. Although Buffett bought the stock decades ago, the business remains one of the best-performing and largest companies in the consumer staples sector. Add in a well-above-market 2.6% dividend yield, and there's a lot to like about Coca-Cola. Expand NYSE : KO Coca-Cola Today's Change ( 0.80 %) $ 0.63 Current Price $ 79.14 Key Data Points Market Cap $340B Day's Range $ 78.26 - $ 79.19 52wk Range $ 63.66 - $ 79.20 Volume 326 Avg Vol 18M Gross Margin 61.55 % Dividend Yield 2.58 ...
Kroger Co. named retail veteran Greg Foran its chief executive officer, as the nation’s largest supermarket operator seeks to reset after a failed mega-merger and the sudden exit of its former leader. Foran, 64, steps in as Kroger’s first external CEO after nearly a yearlong search. The Cincinnati-based retailer ousted CEO Rodney McMullen in March following a probe into his personal conduct , whic...
Kroger Co. named retail veteran Greg Foran its chief executive officer, as the nation’s largest supermarket operator seeks to reset after a failed mega-merger and the sudden exit of its former leader. Foran, 64, steps in as Kroger’s first external CEO after nearly a yearlong search. The Cincinnati-based retailer ousted CEO Rodney McMullen in March following a probe into his personal conduct , which came on the heels of a $24.6 billion merger with Albertsons Cos . being blocked on antitrust grounds. Since then, Kroger has been led by interim chief Ron Sargent , a longtime board member. Foran most recently led Air New Zealand Ltd. following an eight-year stint at Walmart Inc. The appointment marks a homecoming of sorts for the New Zealand native, who is credited for turning around Walmart’s US business in the mid-to-late 2010s. He made Walmart stores cleaner and friendlier, in addition to improving in-stock availability and overall appearance of stores. He left Air New Zealand in October . The hiring of Foran would be an “incremental positive” to the investment case for Kroger after his experience improving results at Walmart, Morgan Stanley analyst Simeon Gutman wrote in a research note to clients. But Foran does inherit a more complex operation, with Kroger owning several retail chains compared to the single banner he oversaw at Walmart, he said. “Foran helped to drive meaningful operational change at Walmart,” Gutman said. Stock Surge Shares of Kroger rose as much as 6.8% in premarket trading on Monday. The stock had advanced 8% this year through Friday, compared with a gain of 1.3% for the S&P 500. Kroger previously said it expected to name an external CEO in early 2026. Foran will join Kroger’s board, with Sargent remaining as its chair. The retailer has posted healthy sales in recent years, as price-sensitive consumers prioritize groceries and other necessities to save money. Under Sargent, it has been accelerating new store openings, closing underperforming one...
This article first appeared on GuruFocus. Eli Lilly (NYSE:LLY) has agreed to pay $350 million upfront to partner with Innovent Biologics on the joint development of new therapies targeting cancer and immune disorders, underscoring continued multinational interest in China's biotech innovation engine. Under the collaboration, Innovent could be eligible for up to $8.5 billion in milestone payments, ...
This article first appeared on GuruFocus. Eli Lilly (NYSE:LLY) has agreed to pay $350 million upfront to partner with Innovent Biologics on the joint development of new therapies targeting cancer and immune disorders, underscoring continued multinational interest in China's biotech innovation engine. Under the collaboration, Innovent could be eligible for up to $8.5 billion in milestone payments, although the companies did not disclose how many programs are included. Following the announcement, Innovent's Hong Konglisted shares rose as much as 8.6% on Monday, reflecting investor optimism around the scale and structure of the agreement. Management commentary suggests this deal represents a departure from traditional asset-specific licensing. Rather than acquiring rights to an existing pipeline drug, the two companies will work together to create entirely new compounds, with Innovent responsible for development from concept through completion of Phase 2 clinical trials in China. Lilly will hold exclusive rights to develop and commercialize these drugs outside China, while Innovent retains rights in its domestic market. Innovent's chief business officer described the structure as placing a global strategic partner alongside the company before compounds are created, which could streamline future global development. The partnership builds on six previous collaborations between Innovent and Lilly across cancer, diabetes, and obesity, and follows Innovent's more recent licensing agreements with Roche (RHHBF) and Takeda. The timing also aligns with a broader surge in cross-border biotech deals, as out-licensing agreements from China to overseas partners reached record levels in 2025, with at least $6 billion in upfront payments and potential deal values of $120 billion, according to JP Morgan. Momentum appears to have carried into the new year, highlighted by AstraZeneca's (NASDAQ:AZN) obesity deal with CSPC Pharmaceutical Group worth up to $18.5 billion, suggesting global ...
Astera Labs announced Monday that it is expanding its global engineering operations with the opening of a new research and development design center in Israel, a move aimed at accelerating work on advanced connectivity solutions for large-scale artificial intelligence infrastructure. The semiconductor company said the Israel center will focus on developing next-generation scale-up fabrics for high...
Astera Labs announced Monday that it is expanding its global engineering operations with the opening of a new research and development design center in Israel, a move aimed at accelerating work on advanced connectivity solutions for large-scale artificial intelligence infrastructure. The semiconductor company said the Israel center will focus on developing next-generation scale-up fabrics for high-bandwidth connectivity protocols, while also advancing research to address data, network and memory bottlenecks in AI training and inference systems. 2 View gallery Astera Labs team ( Photo: Daniel Edri ) Guy Azrad, a veteran semiconductor executive, will lead the new operation as senior vice president of engineering and general manager of Astera Labs Israel. He will be joined by Ido Bukspan, who was named vice president of ASIC engineering. Astera Labs said the expansion reflects a strategic investment in Israel’s semiconductor ecosystem and is intended to create an end-to-end R&D facility capable of supporting the company’s growing AI connectivity platform. The company plans to collaborate with Israeli universities and the local venture ecosystem as part of the initiative. “We’re building an engineering team with a strong focus on execution, covering hardware, silicon, and software solutions, to support the growing adoption of Astera Labs’ Intelligent Connectivity Platform,” Azrad said. “With offices in Tel Aviv and Haifa, the new Israel design center will look to tap into the region's world-class engineering talent to focus on the full chip design flow—from architecture through production, including software and system design for cutting-edge AI fabrics and emerging inference applications.” Azrad brings extensive experience in high-speed networking, compute and Ethernet technologies. He most recently served as vice president of chip design engineering at Google, where he led silicon development for compute applications. Before that, he held senior leadership roles at Ma...
D.A. Davidson says that OpenAI is back on track after correcting several strategic missteps, a shift the firm believes could lift key beneficiaries in its ecosystem such as Oracle . The investment firm sees a brighter future ahead for the artificial intelligence company, upgrading it in a Monday note. Analyst Gil Luria wrote that OpenAI has "corrected several missteps" since September, with the co...
D.A. Davidson says that OpenAI is back on track after correcting several strategic missteps, a shift the firm believes could lift key beneficiaries in its ecosystem such as Oracle . The investment firm sees a brighter future ahead for the artificial intelligence company, upgrading it in a Monday note. Analyst Gil Luria wrote that OpenAI has "corrected several missteps" since September, with the company refocusing on ChatGPT and its core frontier model. "This includes going down the path of turning on ads, which will be critical for increased monetization and reduced cash burn. Management also appears to have realized that they need to align with NVDA, MSFT and AMZN, instead of trying to compete with them," Luria wrote. Over the next few weeks, Luria believes that OpenAI will exceed investors' expectations with regards to its model performance and capital raising, which should help drive significant positive stock performances for the main companies in its orbit. These include Nvidia, Microsoft, CoreWeave and especially Oracle, the analyst wrote. Luria also upgraded Oracle to a buy rating from neutral, further reflecting his optimism when it comes to OpenAI. The analyst stuck by his $180 price target for the stock, which implies that shares of Oracle could rally 26% from their Friday close. Oracle stock has slipped 18% over the past 12 months and nearly 27% this year. ORCL 1Y mountain ORCL 1Y chart "Considering ORCL's move from $345 intraday 9/11/25 to the current $143 and subsequent moves down in NVDA and MSFT tied to OpenAI concerns, we believe the market has overshot to the downside," Luria wrote. But going forward, the analyst has adopted a more bullish stance on Oracle. Specifically, he believes that OpenAI raising another $100 billion in capital by the end of the quarter could benefit Oracle, as this money would help pay for the data centers Oracle is building for OpenAI. "Since the market is currently assigning the OpenAI relationship a negative value, we beli...
Chinese self-driving technology firm Pony AI has started mass production of a robotaxi co-developed with Toyota, taking an important step forward in commercialising autonomous cabs worldwide. The Guangzhou-based company said on Monday that 1,000 driverless cabs of this kind would roll off the production line this year, to be deployed in top-tier mainland Chinese cities. The cars will reinforce Pon...
Chinese self-driving technology firm Pony AI has started mass production of a robotaxi co-developed with Toyota, taking an important step forward in commercialising autonomous cabs worldwide. The Guangzhou-based company said on Monday that 1,000 driverless cabs of this kind would roll off the production line this year, to be deployed in top-tier mainland Chinese cities. The cars will reinforce Pony AI’s plan to operate a total robotaxi fleet of more than 3,000 units in various mainland and overseas markets by the end of 2026. “This milestone marks a new phase of scaled production and commercial deployment for the Pony-Toyota collaboration in robotaxi development and operations,” the company said in a statement. “It also highlights deep synergy between the partners across autonomous driving technology, vehicle manufacturing, and supply chain integration.” Advertisement Toyota is a shareholder of Pony AI and collaborates with the company on producing autonomous cars. “Pony and Toyota are showing that a marriage between a provider of advanced self-driving technology and a powerful car assembler could fuel the growth of robotaxis in populated cities,” said Ding Haifeng, a consultant at Shanghai-based financial advisory firm Integrity. “More Chinese people will see robotaxis or experience them on certain streets this year.” Advertisement According to current standards, robotaxis have level 4 (L4) self-driving capabilities . That meant they did not require human intervention in most circumstances, according to SAE International, a global standards body.
Apollo Global Management ( APO ) declared $0.51/share quarterly dividend , in line with previous. Forward yield 1.53% Payable Feb. 27; for shareholders of record Feb. 19; ex-div Feb. 19. See APO Dividend Scorecard, Yield Chart, & Dividend Growth. More on Apollo Global Management Apollo Global: Limited Upside Even As Credit Fears Ease (Downgrade) Apollo Global Q3: Earnings Beat, Fee Related Earning...
Apollo Global Management ( APO ) declared $0.51/share quarterly dividend , in line with previous. Forward yield 1.53% Payable Feb. 27; for shareholders of record Feb. 19; ex-div Feb. 19. See APO Dividend Scorecard, Yield Chart, & Dividend Growth. More on Apollo Global Management Apollo Global: Limited Upside Even As Credit Fears Ease (Downgrade) Apollo Global Q3: Earnings Beat, Fee Related Earnings +22.8% Apollo Global Management, Inc. (APO) Presents at Goldman Sachs 2025 U.S. Financial Services Conference Transcript Apollo Global Management Non-GAAP EPS of $2.47 beats by $0.43, revenue of $9.86B beats by $8.66B Apollo Global Management Q4 2025 Earnings Preview
Tokyo Electric Power ( TKECF ) ( TKECY ) said Monday it restarted a reactor at the world's largest nuclear power plant after determining the cause of an alarm during a control rod withdrawal from the No. 6 reactor that halted the facility's restart last month. The No. 6 reactor at its Kashiwazaki Kariwa nuclear power plant began to resume Monday, and the unit's power production will be gradually i...
Tokyo Electric Power ( TKECF ) ( TKECY ) said Monday it restarted a reactor at the world's largest nuclear power plant after determining the cause of an alarm during a control rod withdrawal from the No. 6 reactor that halted the facility's restart last month. The No. 6 reactor at its Kashiwazaki Kariwa nuclear power plant began to resume Monday, and the unit's power production will be gradually increased, with a goal of entering commercial operations on March 18; the utility had been aiming for February 26 before the delay. Tepco ( TKECF ) ( TKECY ), the operator of the Fukushima nuclear power plant that suffered a meltdown accident in 2011, is facing public scrutiny to safely bring Kashiwazaki Kariwa back online, and comes as the Japanese government looks to re-establish atomic energy as a viable energy source. Kashiwazaki Kariwa is Tepco's ( TKECF ) ( TKECY ) only remaining operable nuclear plant; No. 6 is one of seven reactors at the site and the first to be restarted, and the No. 7 reactor also has received approval from Japan's nuclear regulator to return to service. ETFs: ( NLR ), ( URA ), ( URNM ) More on uranium and nuclear URA: Warning Signals NLR: This Is Why Uranium Prices Can Soar Like Gold And Silver Uranium 2026: Why I'm Switching ETFs, From URA To NLR
Pornpimone Audkamkong/iStock via Getty Images Wall Street bulls got something of a scare in the first trading week of February 2026. After starting the week strong, the S&P 500 ( SPX ) got clobbered between Tuesday and Thursday before rebounding to end the week at 6,932.30 , up 0.24% from where it closed out the final trading week of January 2026. What clobbered the market in the middle of the wee...
Pornpimone Audkamkong/iStock via Getty Images Wall Street bulls got something of a scare in the first trading week of February 2026. After starting the week strong, the S&P 500 ( SPX ) got clobbered between Tuesday and Thursday before rebounding to end the week at 6,932.30 , up 0.24% from where it closed out the final trading week of January 2026. What clobbered the market in the middle of the week was tightly targeted on companies making big capital expenditures in building out their investments in artificial intelligence (AI) technologies. Google ( GOOGL ) led the market down early in the week after revealing they were doubling their capital expenditures to $185 billion to support building their AI systems. That was followed up by Amazon's ( AMZN ) announcement they plan to spend $200 billion this year on its AI infrastructure. Also during the week, privately held Anthropic unveiled a new generation of its Claude AI system tailored to automate the generation of computer code. That development prompted investors to not just beat the hell out of software development companies but also financial firms that have made large investments in them. That downward action was mitigated by the end of the week as investors rotated toward dividend-paying firms , benefitting the Dow Jones Industrials, which broke through the 50,000 mark . Overall, the combination of things going on within the S&P 500 was enough to keep it on track with the dividend futures-based model 's trajectory associated with investors focusing on the upcoming quarter of 2026-Q2. The latest update of the alternative futures chart shows the S&P 500 has kept within a few percent of that projected level. Although we've already covered the week's biggest market-moving news, there was more that investors absorbed. Here are those additional headlines: Monday, 2 February 2026 Signs and portents for the U.S. economy: Oil falls 5% on US-Iran de-escalation OPEC+ agrees in principle to keep planned pause in oil output ...